MOONLAKE IMMUNOTHERAPEUTICS (MLTX) Gross margin
MOONLAKE IMMUNOTHERAPEUTICS (MLTX) gross margin by fiscal year — reported gross profit divided by reported revenue.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to MLTXSource: SEC XBRL filings · For reference only · Not investment advice
More MLTX financial trends
MLTX RevenueMLTX Net incomeMLTX Net marginMLTX Gross profitMLTX Operating incomeMLTX Operating marginMLTX Operating cash flowMLTX Free cash flowMLTX Capital expendituresMLTX Return on equityMLTX Stock buybacksMLTX Dividends paidMLTX Total assetsMLTX Total liabilitiesMLTX Shareholders’ equityMLTX overview →